The JAK/STAT signaling pathway: from bench to clinic

X Hu, J Li, M Fu, X Zhao, W Wang - Signal transduction and targeted …, 2021 - nature.com
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling
pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellular …

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

K Ghoreschi, A Balato, C Enerbäck, R Sabat - The Lancet, 2021 - thelancet.com
Psoriasis is a chronic inflammatory disease characterised by sharply demarcated
erythematous and scaly skin lesions accompanied by systemic manifestations. Classified by …

Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international …

EJ Brenner, RC Ungaro, RB Gearry, GG Kaplan… - Gastroenterology, 2020 - Elsevier
Background and Aims The impact of Coronavirus disease 2019 (COVID-19) on patients with
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …

Current and future status of JAK inhibitors

DP McLornan, JE Pope, J Gotlib, CN Harrison - The lancet, 2021 - thelancet.com
An enhanced understanding of the importance of Janus kinase (JAK) and signal transducer
and activator of transcription (STAT) signalling in multiple disease states has led to an …

JAK–STAT pathway targeting for the treatment of inflammatory bowel disease

A Salas, C Hernandez-Rocha, M Duijvestein… - Nature reviews …, 2020 - nature.com
Cytokines are involved in intestinal homeostasis and pathological processes associated
with inflammatory bowel disease (IBD). The biological effects of cytokines, including several …

Novel and emerging therapies for inflammatory bowel disease

B Al-Bawardy, R Shivashankar… - Frontiers in …, 2021 - frontiersin.org
Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease are
chronic, relapsing and remitting disorders of intestinal inflammation with potential systemic …

Emerging topical and systemic JAK inhibitors in dermatology

F Solimani, K Meier, K Ghoreschi - Frontiers in immunology, 2019 - frontiersin.org
Accumulating data on cellular and molecular pathways help to develop novel therapeutic
strategies in skin inflammation and autoimmunity. Examples are psoriasis and atopic …

Immunology of inflammatory bowel disease: molecular mechanisms and therapeutics

Q Lu, M Yang, Y Liang, J Xu, H Xu, Y Nie… - Journal of …, 2022 - Taylor & Francis
As a main digestive organ and an important immune organ, the intestine plays a vital role in
resisting the invasion of potential pathogens into the body. Intestinal immune dysfunction …

The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases

W Damsky, D Peterson, J Ramseier… - Journal of Allergy and …, 2021 - Elsevier
Autoimmune and inflammatory diseases are common and diverse, and they can affect
nearly any organ system. Much of the pathogenesis of these diseases is related to …

Evolving therapeutic goals in ulcerative colitis: towards disease clearance

S Danese, G Roda, L Peyrin-Biroulet - … Reviews Gastroenterology & …, 2020 - nature.com
In ulcerative colitis, treating beyond endoscopic healing has shown a reduction of relapse
and hospitalization, pushing for histological remission to be embraced in clinical practice …